BIOTERRORISM UPDATE FOR EMS - PowerPoint PPT Presentation

About This Presentation
Title:

BIOTERRORISM UPDATE FOR EMS

Description:

No Slide Title – PowerPoint PPT presentation

Number of Views:113
Avg rating:3.0/5.0
Slides: 61
Provided by: Information2325
Category:

less

Transcript and Presenter's Notes

Title: BIOTERRORISM UPDATE FOR EMS


1
(No Transcript)
2
(No Transcript)
3
(No Transcript)
4
(No Transcript)
5
(No Transcript)
6
BIOTERRORISM UPDATE FOR EMS
  • ANTONIO NAPOLITANO MD ATTENDING BRIDGEPORT
    HOSPITAL
    JHPC MEDICAL DIRECTOR

7
OUTLINE
  • Overview
  • History
  • Agents most likely to succeed
  • What to look out for
  • What to do

8
WHAT ARE BIOLOGICAL WEAPONS?
  • Microorganisms or biologic toxins used to produce
    death and disease.
  • Components of BWs
  • Payload
  • Munition
  • Delivery system
  • Dispersal mechanism line source vs. point source

9
WHAT MAKES A BIOLOGICAL WEAPON DESIRABLE TO A
BIOTERRORIST????
  • Stable
  • Deliverable as an aerosol
  • Respiratory transmission
  • Particle diameter of 1-5 microns
  • Highly infectious
  • Deadly
  • No effective vaccine

10
DELIVERY METHODS
  • Missile warheads
  • Aerosol generators
  • Airplane/boat
  • Fixed device
  • Food/water contamination
  • Percutaneously

11
WHAT TO LOOK OUT FOR ?
  • Suspect a biological weapons attack if these
    signs of unusual disease clustering is present
  • Large epidemic with unprecedented numbers of ill
    and dying
  • Common exposure site, common complaints in a
    large number of people
  • Unusual diseases for a particular region
  • Multiple simultaneous outbreaks
  • Reports of sick or dying animals/plants
  • Single case of disease by uncommon agent ie
    smallpox, VHF or inhalation anthrax

12
WHAT TO LOOK OUT FOR ?
  • Disease associations to know
  • Widened mediastinum inhalation anthrax
  • Hemorrhagic meningitis inhalation anthrax
  • Vesicular/pustular rash on face/hands with all
    lesions at the same stage of development
    smallpox
  • Symmetrical bulbar palsies and descending
    paralysis botulism toxin
  • Pneumonia and hemoptysis pneumonic plague

13
CATEGORIES OF BWs
  • Category A are highest priority agents
  • Anthrax
  • Botulism
  • Plague
  • Smallpox
  • Tularemia
  • Viral hemorrhagic fever

14
CATEGORY B
  • Second highest priority agents
  • Q fever
  • Brucellosis
  • Glanders
  • Ricin Toxin from Ricinus communis
  • Epsilon Toxin of Clostridium perfringens
  • Staphylococcus Enterotoxin B

15
CATEGORY C
  • Third highest priority agents
  • Nipah virus
  • Hantaviruses
  • Tickborne Hemorrhagic Fever Viruses
  • Tickborne Encephalitis Viruses
  • Yellow Fever
  • Multidrug-resistant Tuberculosis

16
History of Biological Warfare
  • Poisoning of wells by Assyrians in 6th century
    B.C.
  • 1346 Battle of Caffa.
  • Smallpox-infested blankets given to Native
    Americans
  • Japanese biowarfare experiments in Manchuria
    during WWII. Unit 731.
  • Yellow rain in Laos, Kampuchea in 1970s.
  • Iraqi stockpiles found in Gulf War.
  • Aum Shimbun released anthrax spores along with
    sarin into Tokyo subway system in 1995.

17
ANTHRAX
  • First described 3,500 years ago. The first
    vaccine ever invented and milk Pasteur-ization
    were invented to combat this bug.
  • Cutaneous, GI, and Pulmonary forms.
  • Engineered in the Soviet Union to be resistant to
    Doxycycline and Penicillin.
  • A disease of herbivores. Endemic to Balkans,
    Turkey, W. Africa, Spain, C Asia.

18
INCUBATIO N
  • Spores break down at infection site, and the
    organism is picked up by macrophages and
    transported to lymph nodes where they cause
    massive, often hemorrhagic, lympadenopathy..
  • Organisms elaborate toxins as they multiply.
  • Incubation usually 1-6 days but can be seen as
    far as 60 days.
  • 8000-50,000 spores necessary to cause disease

19
ANTHRAX PATHOPHYSIOLOGY
20
CUTANEOUS ANTHRAX
  • Pruritic red papule that necroses after three or
    4 days and becomes a black eschar which sloughs
    off after 2-3 weeks.
  • 5-25 of cases become systemic or fatal. Excising
    the eschar can cause dissemination.
  • Mortality untreated cases 20. Treatedlt1.

21
(No Transcript)
22
(No Transcript)
23
GASTROINTESTINAL ANTHRAX
  • Very rare, need to ingest spores in contaminated
    meat or large numbers of spores in water.
  • Presentation depends on area of GI tract affected
  • Fulminant peritonitis, mesenteric lymphadenitis
    and septicemia.
  • Mortality25-60 all comers.

24
PULMONARY ANTHRAX
  • Very rare but VERY LETHAL
  • Early on easy to confuse with a viral illness.
  • To date none of the 10 index cases have had
    rhinorrhea associated with them. All had positive
    CXRs
  • After 2-3 days of the above ( The patient may
    actually improve) the patient rapidly progresses
    to respiratory distress,shock and death.
  • Hemorrhagic meningitis is common

25
CXR OF PULMONARY ANTHRAX
  • Widened mediastinum shown at right.
  • Pleural effusions common, usually hemorrhagic.
  • Most toxic patients also have hemorrhagic
    meningitis.
  • Chest wall edema.

26
PULMONARY ANTHRAX- CONTINUED
  • This disease is so rare that even as few as two
    cases can be interpreted as evidence that a
    biologic attack is being waged.
  • Diagnosis mad by Blood, CSF, or pleural fluid.
  • Mortality 89- 100 (Pre antibiotic Critical Care
    era.

27
TREATMENT
  • Largely supportive
  • Ciprofloxacin or Doxycycline the initial
    therapy, given the high incidence of Penicillin
    resistance. Can adjust therapy based on culture
    results
  • Therapy must be continued for 60 days given the
    persistant germination of spores.

28
VACCINE
  • Available in the UK and USA.
  • Purified Protective Antigen adsorbed onto
    aluminum adjuvant.
  • Six .5 cc shots over 18 months military feels
    that a three shot series will protect individual
    for 6 months after series.
  • Local reactions common.(6) Dont give to people
    with prior exposure

29
NO DATA THAT ANY OF THESE WILL PROTECT FROM AN
AEROSOL CHALLENGE!!!!!
  • ANTIBIOTIC PROPHYLAXIS RECOMENDED FOR ANY
    IMMINENT BIOLOGIC WEAPON!

30
PLAGUE
  • Zoonotic disease transmitted by infected fleas or
    by aerosol in a biologic. Person to person also
    seen in Pneumonic plague.
  • 30 types of fleas and over 200 different mammals
    can harbor the bacteria.
  • Move to Australia or Antarctica.
  • Bubonic, septicemic, and inhalation syndromes all
    known.

31
BUBONIC
  • 1-10 day incubation period then high fever
    malaise and purulent lymphadenopathy of the
    groin, but also seen in cervical and axillary
    lymph nodes, and a plethora of rashes seen.
  • 80 of these patients blood culture positive but
    only 25 progress to the septicemic form.

32
(No Transcript)
33
SEPTICEMIC PLAGUE
  • These patients behave like your basic septic
    patient fever chills hypotension and shock plus
    often nausea, vomiting and diarrhea.
  • Often develop acral thrombosis clotting and
    gangrene of extremities, and skin with more
    proximal purpura.
  • Can progress to pnumonic both by bloodstream and
    inhalation.

34
(No Transcript)
35
(No Transcript)
36
PNEUMONIC
  • 2-3 DAY INCUBATION FOR BOTH.
  • Cough, dyspnea sputum/blood, toxemia, rapidly
    progressing to acute respiratory failure. CXR
    shows patchy bilateral alveolar infiltrates
  • Preterminal events are circulatory collapse
    hemorrhage and peripheral thrombosis in
    septicemic and bubonic.
  • Mortality 50bubonic and septicemic, 100 for
    pneumonic.

37
Pneumonic Plague
  • 2-3 day incubation period
  • Non-specific complaints, but hemoptysis is common
  • Secondary transmission is possible
  • Treatment streptomycin IM or IV gentamicin or IV
    doxycycline
  • Prophylaxis po ciprofloxacin or doxycycline

38
(No Transcript)
39
MORTALITY FROM PLAGUE
  • Pulmonary form still 50 mortality even with
    antibiotics. Less than 5 with the other forms.
  • Death most likely even with therapy if treatment
    delayed beyond 18 hours of infection. Again Cipro
    and Doxycycline.
  • These facts plus a flea vector and person to
    person make plague a serious threat.

40
OTHER BACTERIAL BIOLOGICS
  • Tularemia- Non spore bacterium that spreads by
    skin, mucosa, GI, and Pulmonary(as few as 50
    organisms needed for pulmonary infection.)
  • Arthropods, contact, ingestion, handling of meat
    or inhalation are potential vectors.
  • Glandular, septicemic, pneumonic,forms seen as
    well as ulceroglandular and oculoglandular

41
(No Transcript)
42
(No Transcript)
43
OTHER BACTERIAL AGENTS
  • Cholera Darkfield and Phase contrast microscopes
    and culture. IV therapy for vomiting, losing
    greater than 7 liters a day, and shock. Killed
    vaccine that only protects for 6 months. Bactrim,
    Doxy, and TMP/SMX.
  • Pssitacosis(Parrot fever) 1-2 weeks incubation
    aerosolized dried droppings, aerosol and human to
    human. Fever Nausea, vomiting,myalgias and
    atypical pneumonia. Erythromycin and Doxycline.
  • Brucellosis

44
THE VIRAL WEAPONS
  • Smallpox
  • Q fever (rickettsial)
  • Venezuelan Equine Encephalitis
  • Anything else

45
SMALLPOX
  • First described 2000 years ago.
  • ? Origin in India, or Western Asia.
  • Reached Europe by 700 AD.
  • It killed more American Indians than European
    bullets in its spread to North America. (in the
    French Indian War we gave Indians blankets known
    to have come from smallpox patients).

46
SMALLPOX
  • Variola virus and Orthopox virus.
  • Last wild case reported in 1977.
  • Transmitted by face-face, secretions, and
    aerosols.
  • Aerosols are deactivate by UV light within 24
    hours. So SUPPOSEDLY patients presenting ill
    probably not need to be decontaminated.

47
THE FACE OF SMALLPOX
48
(No Transcript)
49
FACTS ABOUT SMALLPOX
  • Approximately 10-17 day incubation period ending
    in a 2-3 day viral prodrome (fever, headache,
    neck and backache).
  • Rash follows soon afterwards. Starts as macules,
    turning to papules, which become vesicles and
    lastly pustules which crust over by approximately
    the 10th day.
  • If you have the rash you are infectious.

50
FACTS ABOUT SMALLPOX.
  • Variola Major and minor. Major was displayed on
    the previous slide and Minor is just less intense
    (look at day 3).
  • Minor most likely manifestation in partially
    immunized folks.
  • Two variants Hemorrhagic and Malignant. Both
    have shorter prodromes. Former rapidly progresses
    to DIC like picture, and the latter becomes
    fulminant before vesicles/pustules form.
    Hemorrhagic Smallpox especially common in
    pregnant females.

51
FACTS ABOUT SMALLPOX
  • Complications are scarring (keratitis with ocular
    involvement), smallpox pneumonia, and arthritis
    which can cause permanent deformities.
  • Obviously if this got out, medical resources
    would be severely depleted beyond the 25
    mortality projected for the disease.
  • All pediatric and most adults not immune.
  • Many more older, immunosuppressed people to deal
    with than in the past.

52
FACTS ABOUT SMALLPOX
  • The one thing that slows its spread is the fact
    that the patient is so ill that they are usually
    bed bound by the time the rash appears.
  • In a hospital this can be disastrous. In Germany
    one case with a cough in isolation managed to
    contaminate THREE FLOORS of a hospital. Disease
    can pass 10-20 generations from a single index
    case.
  • Think about spring breaks and Disney World.

53
Therapy
  • Ribavirin, cidfovir and a derivative of the
    latter are available but have never actually been
    used in a smallpox case.
  • Vaccination within 4 days of exposure has been
    shown to decrease both the course and mortality
    of the disease.
  • In the event of an outbreak we all need a shot.
  • Diagnosis clinical, but DFA, electron microscopy
    and culture are all available. Which depends on
    facility.

54
SMALLPOX
  • WHO has approximately 500,000 vaccines available.
  • USA approximately 10 million with an additional
    50-60 million in various locations.
  • A question of potency and adequate storage of
    these vaccines has been raised.
  • Problem in the immunosuppressed.
  • 18 deaths in the 1961-62 in UK epidemic

55
SMALLPOX
  • All possessions of the patient need to be steam
    cleaned or cleansed in bleach or other hospital
    grade cleanser.
  • Clothes and sheets should be autoclaved.
  • This is where I disagree with recommendations
    that patients presenting with smallpox dont need
    decontamination.
  • Potential exposure with fever gt101 is isolated
    before they have a rash and infect others!!!!!!

56
Q FEVER
  • Coxiella Burnetti, not a virus but a rickettsia
    10-20 day incubation followed by a self limited
    illness 2days to 2weeks. Pneumonia is common and
    atypical in presentation, and hepatitis seen in
    1/3 of the cases. One inhaled organism can cause
    disease.
  • Complications include chronic hepatis,
    endocarditis, meningitis,encephalitis and
    osteomyelitis
  • Diagnosis is by ELISA,Doxycycline and
    Erythromycin.

57
Venezuelan Equine Encephalitis
  • VEE for short. There is also Western and Eastern
    (WEE and EEE).
  • Arthropods and aerosol. No evidence of Horse to
    Human or Human to Human transmission. ELISA Tests
    for Dx.
  • 1-6 day incubation, 24-72 hour acute phase of
    fevers,rigors,headache,malaise, photophobia and
    myalgias.

58
Viral Hemorrhagic Fever
  • Ebola/Marburg/Lassa
  • Easily grown/ highly infectious when aerosolized
  • Symptoms fever, malaise, signs of vascular
    permeability
  • Conjunctival injection
  • Hypotension
  • Flushing
  • Petechial hemorrhage
  • Treatment supportive
  • ? ribavirin

59
Botulism Toxin
  • Most potent toxin known
  • Easily isolated
  • Can be food-borne or aerosolized
  • IP 3-8 days if acquired po, 24-36 hours if
    inhaled
  • Diagnosis clinical
  • Bulbar palsies, descending paralysis, respiratory
    failure
  • No fever
  • Treatment supportive
  • Antitoxin available from CDC or military

60
ANY QUESTIONS???????
  • Thank you very much.
Write a Comment
User Comments (0)
About PowerShow.com